Literature DB >> 9376072

The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.

G H Rhodes1, J R Valbracht, M D Nguyen, J H Vaughan.   

Abstract

In infectious mononucleosis (IM), anti-EBNA-1 antibodies are produced which cross-react with multiple normal human proteins. The cross-reactions can be inhibited with synthetic peptides representing the glycine/alanine repeat in EBNA-1, which implies that the cross-reactivity is due to anti-gly/ala antibodies that cross-react with host proteins containing configurations like those in the EBNA-1 repeat. Here we report the isolation of five gene fragments from a Raji B lymphocyte cDNA library encoding peptides reactive with autoantibodies in an IM serum. One of these, p542, encodes a glycine rich 28-mer which constitutes its cross-reactive epitope, as shown elsewhere. By Northern blots, p542 was identifiable in three B lymphocyte lines, a T cell line, and an epithelial cell line. In a search of the GenBank for proteins with sequence similarity to p542, we found a high degree of identity with the mid- and 3' terminal regions of the recently published mouse gene, Raly, which encodes a protein with the structure of a heterogeneous nuclear ribonuclear protein (hnRNP). We confirmed by anchored RT-PCR our presumption that the 5' sequences of p542 also have a high degree of identity with Raly, including presence of RNA binding motifs characteristic of hnRNPs. There was also sequence homology with human hnRNP C2. From these observations and our previous studies, we conclude that the autoantigen for one of the cross-reactive autoantibodies generated during immune responses to the Epstein Barr virus, anti-p542, is probably an hnRNP. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376072     DOI: 10.1006/jaut.1997.9996

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  10 in total

1.  A novel cDNA encodes a putative hRALY-like protein, hRALYL.

Authors:  Chao-Neng Ji; Jin-Zhong Chen; Yi Xie; Shu Wang; Ji Qian; Enpeng Zhao; Wei Jin; Xiao-Zhou Wu; Wan-Xiang Xu; Kang Ying; Yu-Min Mao
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

2.  Mechanisms of activation and repression by the alternative splicing factors RBFOX1/2.

Authors:  Shuying Sun; Zuo Zhang; Oliver Fregoso; Adrian R Krainer
Journal:  RNA       Date:  2011-12-19       Impact factor: 4.942

3.  Long noncoding RNA EMS connects c-Myc to cell cycle control and tumorigenesis.

Authors:  Chenfeng Wang; Yang Yang; Guang Zhang; Jingxin Li; Xianning Wu; Xiaoling Ma; Ge Shan; Yide Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-01       Impact factor: 11.205

4.  The hnRNP RALY regulates transcription and cell proliferation by modulating the expression of specific factors including the proliferation marker E2F1.

Authors:  Nicola Cornella; Toma Tebaldi; Lisa Gasperini; Jarnail Singh; Richard A Padgett; Annalisa Rossi; Paolo Macchi
Journal:  J Biol Chem       Date:  2017-09-27       Impact factor: 5.157

5.  Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus.

Authors:  I-Ju Liu; Chien-Yu Chiu; Yun-Ching Chen; Han-Chung Wu
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

6.  Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.

Authors:  D Lang; R Vornhagen; M Rothe; W Hinderer; H H Sonneborn; B Plachter
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

7.  RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS.

Authors:  Zhao Liang; Buzukela Abuduaini; Aliya Rehati; Erhati Husaiyin; Dong Chen; Zhang Jiyuan
Journal:  Genes Immun       Date:  2022-08-08       Impact factor: 4.248

8.  Antibodies specific for Epstein-Barr virus nuclear antigen-1 cross-react with human heterogeneous nuclear ribonucleoprotein L.

Authors:  J William Lindsey; Samantha L deGannes; Kimberly A Pate; Xiurong Zhao
Journal:  Mol Immunol       Date:  2015-11-28       Impact factor: 4.407

9.  Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.

Authors:  Barbara C Gärtner; Ralf D Hess; Dirk Bandt; Alexander Kruse; Axel Rethwilm; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  Clin Diagn Lab Immunol       Date:  2003-01

10.  Identification and dynamic changes of RNAs isolated from RALY-containing ribonucleoprotein complexes.

Authors:  Annalisa Rossi; Albertomaria Moro; Toma Tebaldi; Nicola Cornella; Lisa Gasperini; Lorenzo Lunelli; Alessandro Quattrone; Gabriella Viero; Paolo Macchi
Journal:  Nucleic Acids Res       Date:  2017-06-20       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.